I

Intra-Cellular Therapies

ITCI

79.030
USD
0.26
(0.33%)
Market Open
Volume
5,036
EPS
0
Div Yield
0
P/E
-89
Market Cap
8,120,503,186
Related Instruments
A
ACAD
-0.020
(-0.11%)
19.000 USD
A
AGIO
-1.950
(-4.20%)
44.520 USD
A
ALKS
-0.440
(-1.61%)
26.860 USD
A
ALNY
31.19
(13.13%)
268.66 USD
E
ESPR
-0.13000
(-5.62%)
2.18500 USD
I
INSM
2.510
(3.45%)
75.330 USD
J
JAZZ
3.940
(3.57%)
114.330 USD
L
LGND
-4.760
(-4.36%)
104.410 USD
S
SAGE
-1.21000
(-11.03%)
9.76000 USD
News

Title: Intra/Cellular Therapies

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that addressneeds in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.